Analysts think LIVN stock price could increase by 35%
Oct 24, 2024, 11:25 AM
-3.17%
What does LIVN do
LivaNova Plc is a global medical technology company that develops therapeutic solutions across three segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support. Their products include heart-lung machines, neuromodulation devices, and life support systems.
12 analysts think LIVN stock price will increase by 34.72%. The current median analyst target is $71.40 compared to a current stock price of $53.00. The lowest analysts target is $60.60 and the highest analyst target is $94.50.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
